Crossmark

Trastuzumab-induced human cardiomyocyte damage through the Notch2/JAK2/STAT3 pathway

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2023.100268

Published Print: 2023-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Su, Zhenbo http://orcid.org/0000-0002-7483-7765
Liu, Siyao http://orcid.org/0009-0009-7131-2187
Zou, Yinggang http://orcid.org/0000-0001-8659-6543
Shan, Liang http://orcid.org/0009-0004-6085-1058
Yu, Miao http://orcid.org/0009-0009-5820-3242
Xie, Shishun http://orcid.org/0009-0004-5662-5795
Li, Xiangjun http://orcid.org/0000-0002-8986-7203
Jin, Ying http://orcid.org/0000-0002-1457-9581
Funding

Funding for this research was provided by:

Health Commission of Jilin Province

Department of Finance of Jilin Province (3D517EC93430)
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2023-07-28
More Information

This article is maintained by: Elsevier

Article Title: Trastuzumab-induced human cardiomyocyte damage through the Notch2/JAK2/STAT3 pathway

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2023.100268

Content Type: article

Copyright: © 2023 HCFMUSP. Published by Elsevier España, S.L.U.